Omisirge (omidubicel-onlv) Coverage Criteria
Customize your policy alerts
Sign up for all Premera Bluecross policy alerts
Know when Premera Bluecross releases new policies or updates existing guidance.
Monitor payer policy activity
Medical-benefit coverage and authorization for Omisirge in individuals with hematologic malignancies or severe aplastic anemia who meet specified age, transplant, donor-availability, conditioning, prescribing, and administration criteria.
Coverage criteria were added for Omisirge (omidubicel-onlv) in adults and pediatric individuals 6 years and older with severe aplastic anemia following reduced-intensity conditioning.
The hematologic-malignancy criteria for Omisirge were updated to remove the requirement that the individual have no history of prior allogeneic hematopoietic stem cell transplant.
HCPCS code J3406 was added for Omisirge.
HCPCS codes C9399 and J3590 were removed for Omisirge.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.